F Fuzkk Atlas of the USA
#457Extended selection 101–500

CordenPharma US

Other / National Manufacturing

API / CDMO / manufacturing

Manufacturing profile

API / CDMO / manufacturing

Biopharma hub: Other / National Manufacturing

Selection basis

The company is placed in positions 101–500 as a manufacturer, biotech, generics, advanced-therapy company or CDMO with practical relevance to the FUZKK utility catalog.

The Top 500 is a FUZKK atlas priority rather than a single official revenue table. Inclusion in an FDA or industry source does not mean product approval, confirmation of a site's current status or actual use of FUZKK.

Representative manufacturing and QC chain

  1. 1Route development, raw materials and scale-up
  2. 2Synthesis, bioprocessing or formulation development
  3. 3Purification, filtration, drying or aseptic processing
  4. 4Technology transfer, cleaning and change control
  5. 5HPLC/GC/KF/ICP/LC-MS and validation evidence

Relevant FUZKK packages

United States: national essential medicines QC packageGlobal API & Biosimilars QC SuiteWorld API Extension QC SuiteFermentation & Antibiotic Intermediates QC SuiteLumex QC Suite

Product/API utilities

—

Lumex — instrumental QC

Method Validation Data Packager

LabEx — laboratory QC

Assay & Impurity HPLC Quality CheckerResidual Solvents GC Quality CheckerWater Content KF Quality CheckerElemental Impurities ICP Quality CheckerLC-MS Confirmation Quality Checker

Medical Devices — equipment and software lifecycle

Process Validation CheckerChange Control Impact CheckerSupplier Evaluation CheckerProduction Record Consistency CheckerCalibration Status CheckerRequirement Traceability CheckerData Integrity Security Checker

Suggested first pilot

  1. Confirm one real product, method or recurring QC review.
  2. Record the instrument, export format and current specification.
  3. Select 3–7 utilities from the map above.
  4. Run a PASS/FAIL sample and agree the expected output.
  5. After user validation, expand to other products and sites.

Mapping boundary

The Top 500 is a FUZKK atlas priority rather than a single official revenue table. Inclusion in an FDA or industry source does not mean product approval, confirmation of a site's current status or actual use of FUZKK.

Methodology